Navigation Links
CryoCath to Hold Third Quarter 2008 Conference Call and Webcast
Date:7/30/2008

http://www.cryocath.com

Toronto Stock Exchange Symbol: CYT

MONTREAL, July 30 /PRNewswire-FirstCall/ - CryoCath (TSX: CYT), will hold a conference call to discuss its third quarter 2008 financial results at 9:00 a.m. (Eastern Time) on Tuesday, August 5, 2008. The call will be hosted by Mr. Jan Keltjens, President and CEO and Mrs. Ginette Gagne, CFO. The Company will report its results in a press release to be issued at 7:00 a.m on Tuesday, August 5.

DATE: Tuesday, August 5, 2008

TIME: 9:00 a.m., Eastern Time

DIAL IN NUMBER: 416-644-3427 or 1-866-250-4892

TAPED REPLAY: 416-640-1917 or 1-877-289-8525

REFERENCE NUMBER: 21279395 followed by the number sign

WEBCAST: A live audio webcast of the call will be available

at http://www.cryocath.com. Webcast attendees are welcome

to listen to the conference in real-time or

on-demand at their convenience. The webcast will be

archived for 365 days. Please connect to this

website at least 15 minutes prior to the conference

call to ensure adequate time for any software

download that may be needed to hear the webcast.

A question and answer session will follow, at which time the operator will direct participants as to the correct procedure for submitting questions.

About CryoCath

CryoCath - http://www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.

This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at http://www.sedar.com under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.


'/>"/>
SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CryoCath Appoints Vice President, Europe
2. CryoCath Presents at Prestigious Heart Rhythm Society Meeting
3. CryoCath Announces Fiscal 2008 Second Quarter Results
4. CryoCath to Hold Second Quarter 2008 Conference Call and Webcast
5. CryoCath Reports Data Presented at the 74th Annual Meeting of the German Cardiac Society
6. CryoCath Introduces Arctic Front in Australia
7. CryoCath Appoints New Chief Financial Officer
8. CryoCath Technologies notice of annual meeting
9. CryoCath Announces Fiscal 2008 First Quarter Results
10. CryoCath Provides Update on Patent Infringement Lawsuit
11. CryoCath to Hold First Quarter 2008 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., ... analytics, today announced that it has been ranked #1 by ... Black Book™ Rankings 2017 User Survey. ZirMed was recognized ... for large hospitals and medical centers over 200 beds and ... Book,s healthcare technology user survey history. ...
Breaking Medicine Technology: